---
figid: PMC10892479__pathogens-13-00164-g005
figtitle: Illustrates a diagrammatic representation of the intracellular signaling
  pathways activated by SARS-CoV-2 infection
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10892479
filename: PMC10892479__pathogens-13-00164-g005.jpg
figlink: /pmc/articles/PMC10892479/figure/F5
number: F5
caption: 'Illustrates a diagrammatic representation of the intracellular signaling
  pathways activated by SARS-CoV-2 infection. Specific drugs targeting these pathways
  are repurposed to regulate the excessive release of cytokines induced by the viral
  infection. CCL3: Chemokine (C-C motif) ligand 3; G-CSF: Granulocyte-colony stimulating
  factor; GM-CSF: Granulocyte macrophage-colony stimulating factor; IκB: Inhibitor
  of nuclear factor-κB; JAK: Janus kinase; IL: Interleukin; IP-10: Interferon-γ-induced
  protein-10; MCP-1: Monocyte chemoattractant protein-1; MyD88: Myeloid differentiation
  primary response gene 88; NF-κB: Nuclear factor-κB; S1P: Sphingosine-1-phosphate;
  S1PR1: Sphingosine-1-phosphate receptor 1; STAT: Signal transducer and activator
  of transcription; TNFα: Tumor necrosis factor α; TLR: Tol-like receptor; TRIF: TIR-domain-containing
  adapter-inducing IFN-β. (Adapted and updated with permission from Catanzaro et al.
  [161])'
papertitle: The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection
reftext: Periyanaina Kesika, et al. Pathogens. 2024 Feb;13(2).
year: '2024'
doi: 10.3390/pathogens13020164
journal_title: Pathogens
journal_nlm_ta: Pathogens
publisher_name: MDPI
keywords: COVID-19 | SARS-CoV-2 | NF-κB | inflammation | cytokines
automl_pathway: 0.9543319
figid_alias: PMC10892479__F5
figtype: Figure
redirect_from: /figures/PMC10892479__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10892479__pathogens-13-00164-g005.html
  '@type': Dataset
  description: 'Illustrates a diagrammatic representation of the intracellular signaling
    pathways activated by SARS-CoV-2 infection. Specific drugs targeting these pathways
    are repurposed to regulate the excessive release of cytokines induced by the viral
    infection. CCL3: Chemokine (C-C motif) ligand 3; G-CSF: Granulocyte-colony stimulating
    factor; GM-CSF: Granulocyte macrophage-colony stimulating factor; IκB: Inhibitor
    of nuclear factor-κB; JAK: Janus kinase; IL: Interleukin; IP-10: Interferon-γ-induced
    protein-10; MCP-1: Monocyte chemoattractant protein-1; MyD88: Myeloid differentiation
    primary response gene 88; NF-κB: Nuclear factor-κB; S1P: Sphingosine-1-phosphate;
    S1PR1: Sphingosine-1-phosphate receptor 1; STAT: Signal transducer and activator
    of transcription; TNFα: Tumor necrosis factor α; TLR: Tol-like receptor; TRIF:
    TIR-domain-containing adapter-inducing IFN-β. (Adapted and updated with permission
    from Catanzaro et al. [161])'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - IL6
  - LINC00689
  - NFKB1
  - TNF
  - TLR3
  - TLR7
  - TLR8
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - TRIM69
  - TICAM1
  - MYD88
  - CXCL8
  - IL17A
  - IL2
  - IL1A
  - IL1B
  - CXCL10
  - CSF2
  - CSF3
  - CCL3
  - CCL2
  - S1PR1
  - S1PR2
  - S1PR3
  - S1PR4
  - S1PR5
  - MBTPS1
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - PPBP
  - Serine protease inhibitors
  - Fingolimod
  - S1P
---
